2015
DOI: 10.1007/s11845-015-1257-x
|View full text |Cite
|
Sign up to set email alerts
|

Port site metastatic disease in ovarian carcinoma

Abstract: In all cases, port-site metastatic disease developed rapidly and was clinically suspected at the time of definitive surgery. We recommend that consideration be given towards removing port sites when performing cytoreductive surgery for gynaecological malignancy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Besides the contamination from port catheters and tissue manipulation, pneumoperitoneum, hypercapnia and CO 2 acidemia have been shown to participate in the metastases, while no preventive measure (e.g., oxaliplatin) has been found successful enough. Similarly, the use of paracentesis ascites catheters, and fine-needle biopsy have caused the same complications [24,25,26].…”
Section: Pathways and Metastatic Sites Of Ovarian And Peritoneal Cmentioning
confidence: 99%
“…Besides the contamination from port catheters and tissue manipulation, pneumoperitoneum, hypercapnia and CO 2 acidemia have been shown to participate in the metastases, while no preventive measure (e.g., oxaliplatin) has been found successful enough. Similarly, the use of paracentesis ascites catheters, and fine-needle biopsy have caused the same complications [24,25,26].…”
Section: Pathways and Metastatic Sites Of Ovarian And Peritoneal Cmentioning
confidence: 99%